Lawyers Say Jackson’s Supreme Court Impact Could Be Felt On Administrative, Patent Cases
Executive Summary
As confirmation hearings for Judge Ketanji Brown Jackson continue, MTI took a look at some of the core areas at stake.
You may also be interested in...
Court Blocks FDA’s Attempt To Ban Electroshock Device
The DC Circuit Court of Appeals says the US agency can’t ban a device for certain indications while allowing it to remain on the market for others.
Attorney: Expect PTO Director To Use ‘Discretion’ In New Patent Appeal Authority
The US Supreme Court found that the role of administrative judges in patent review was unconstitutional but could be fixed by giving the PTO’s director more oversight, reinforcing the staying power of the patent appeals process.
RSV Vaccine May Be On Market In 2023, CDC’s ACIP Anticipates
Panel expects to review five respiratory syncytial virus vaccines and vote on one or two of them in June 2023 and others four months later. Sanofi presents results of three clinical trials of its monoclonal antibody nirsevimab, which is on track to be the second RSV prophylaxis for infants.